Estrid Studios AB

Based in Sweden, Estrid Studios AB offers subscription-based razor and personal care products aimed at a diverse clientele, including women, men, and non-binary individuals, enhancing grooming experiences with convenience and quality. Founded in 2019 in Stockholm, Sweden, Estrid Studios AB specializes in providing personal care products, primarily focused on a razor subscription service. The company was established by Alan Aygun, Amanda Westerbom, and Ben Eliass. In October 2022, Estrid raised SEK 150 million in funding, bringing the total amount raised to SEK 150 million with a current company valuation of SEK 846.

42 million. The latest deal was facilitated by CamStent Ltd. Estrid specializes in subscription-based razor and personal care products designed for a diverse clientele, including women, men, and non-binary individuals. The company's core offering is a razor subscription service that delivers high-quality, super-sharp razor blades to customers' doorsteps.

Estrid addresses common shaving issues such as skin irritation and discomfort and promotes a sustainable approach with vegan and cruelty-free product formulations enriched with nourishing ingredients. The company operates primarily in European markets, including Sweden, Denmark, Germany, and the United Kingdom. In 2022, Estrid reported a revenue of EUR 42,375,444. 60 and an EBITDA of EUR -21,060,629.

20. The subscription model allows customers to receive regular shipments of razor refills at a standard price of EUR 11. 95 per shipment, ensuring consistent cash flow and customer retention through a lifetime guarantee on its stainless steel handles. Following the SEK 100 million venture debt funding raised in October 2022, Estrid Studios AB plans to expand its product offerings and geographical reach.

The company is evaluating new product designs targeting the personal care market with anticipated releases in the coming year. Estrid aims to penetrate additional European markets to further enhance its customer base and revenue streams.